Trade GENB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Generate Biomedicines, Inc. (GENB) is trading at US$15.72, up 2.14% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$2.07B. Over the past 52 weeks, GENB has traded between US$11.00 and US$22.67. On Syfe you can trade GENB with $0 commission and add it to your watchlist.
| Previous close | US$15.39 |
|---|---|
| Market cap | US$2.07B |
| 52-week range | US$11.00 – US$22.67 |
| Volume | 665.9K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
Year: 2026
Generate Biomedicines Shares Fall Following Q2 Financial Results
Aug 6, 5:51 PM · MT Newswires
-- Earnings Flash (GENB) Generate Biomedicines Inc. Reports Q2 Revenue $6.3M
Aug 6, 11:14 AM · MT Newswires
Morgan Stanley Lifts Price Target on Generate Biomedicines to $22 From $20, Keeps Overweight Rating
May 14, 11:04 AM · MT Newswires
--Earnings Flash (GENB) Generate Biomedicines Posts Q1 Net Loss $61.4M, vs. FactSet Est of $61.2M Loss
May 7, 10:22 AM · MT Newswires
Generate Biomedicines, Inc. (GENB) stock is trading at US$15.72, +2.14% from the previous close of US$15.39.
The market cap for Generate Biomedicines, Inc. (GENB) stock is approximately US$2.07B.
The 52-week high for Generate Biomedicines, Inc. (GENB) stock is US$22.67.
The 52-week low for Generate Biomedicines, Inc. (GENB) stock is US$11.00.
Generate Biomedicines, Inc. (GENB) does not currently pay a dividend.
Stay on top of GENB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
